Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP

被引:113
作者
Sayós, J
Martín, M
Chen, A
Simarro, M
Howie, D
Morra, M
Engel, P
Terhorst, C
机构
[1] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Immunol, Boston, MA 02215 USA
[2] Univ Barcelona, Sch Med, Immunol Unit, Dept Cellular Biol & Pathol,IDIBAPS, Barcelona, Spain
关键词
D O I
10.1182/blood.V97.12.3867
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
X-linked lymphoproliferative disease (XLP) is a rare immune disorder commonly triggered by infection with Epstein-Barr virus. Major disease manifestations include fatal acute infectious mononucleosis, B-cell lymphoma, and progressive dys-gammaglobulinemia. SAP/SH2D1A, the product of the gene mutated in XLP, is a small protein that comprises a single SH2 domain and a short tail of 26 amino acids. SAP binds to a specific motif in the cytoplasmic tails of the cell surface receptors SLAM and 2B4, where it blocks recruitment of the phosphatase SHP-2. Here it is reported that Ly-9 and CD84, 2 related glycoproteins differentially expressed on hematopoietic cells, also recruit SAP. Interactions between SAP and Ly-9 or CD84 were analyzed using a novel yeast 2-hybrid system, by COS cell transfections and in lymphoid cells. Recruitment of SAP is most efficient when the specific tyrosine residues in the cytoplasmic tails of Ly-9 or CD84 are phosphorylated. It is concluded that in activated T cells, the SAP protein binds to and regulates signal transduction events initiated through the engagement of SLAM, 2B4, CD84, and Ly-9, This suggests that combinations of dysfunctional signaling pathways initiated by these 4 cell surface receptors may cause the complex phenotypes of XLP (C) 2001 by The American Society of Hematology.
引用
收藏
页码:3867 / 3874
页数:8
相关论文
共 25 条
[1]   SLAM and its role in T cell activation and Th cell responses [J].
Aversa, G ;
Carballido, J ;
Punnonen, J ;
Chang, CCJ ;
Hauser, T ;
Cocks, BG ;
DeVries, JE .
IMMUNOLOGY AND CELL BIOLOGY, 1997, 75 (02) :202-205
[2]  
Aversa G, 1997, J IMMUNOL, V158, P4036
[3]   Cutting edge: Defective NK cell activation in X-linked lymphoproliferative disease [J].
Benoit, L ;
Wang, XX ;
Pabst, HF ;
Dutz, J ;
Tan, R .
JOURNAL OF IMMUNOLOGY, 2000, 165 (07) :3549-3553
[4]   2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48 [J].
Brown, MH ;
Boles, K ;
van der Merwe, PA ;
Kumar, V ;
Mathew, PA ;
Barclay, AN .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (11) :2083-2090
[5]  
Carballido JM, 1997, J IMMUNOL, V159, P4316
[6]   A NOVEL RECEPTOR INVOLVED IN T-CELL ACTIVATION [J].
COCKS, BG ;
CHANG, CCJ ;
CARBALLIDO, JM ;
YSSEL, H ;
DEVRIES, JE ;
AVERSA, G .
NATURE, 1995, 376 (6537) :260-263
[7]   Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene [J].
Coffey, AJ ;
Brooksbank, RA ;
Brandau, O ;
Oohashi, T ;
Howell, GR ;
Bye, JM ;
Cahn, AP ;
Durham, J ;
Heath, P ;
Wray, P ;
Pavitt, R ;
Wilkinson, J ;
Leversha, M ;
Huckle, E ;
Shaw-Smith, CJ ;
Dunham, A ;
Rhodes, S ;
Schuster, V ;
Porta, G ;
Yin, L ;
Serafini, P ;
Sylla, B ;
Zollo, M ;
Franco, B ;
Bolino, A ;
Seri, M ;
Lanyi, A ;
Davis, JR ;
Webster, D ;
Harris, A ;
Lenoir, G ;
St Basile, GD ;
Jones, A ;
Behloradsky, BH ;
Achatz, H ;
Murken, J ;
Fassler, R ;
Sumegi, J ;
Romeo, G ;
Vaudin, M ;
Ross, MT ;
Meindl, A ;
Bentley, DR .
NATURE GENETICS, 1998, 20 (02) :129-135
[8]  
delaFuente MA, 1997, BLOOD, V90, P2398
[9]  
GARNIWAGNER BA, 1993, J IMMUNOL, V151, P60
[10]   The gene defective in X-linked lymphoproliferative disease controls T cell dependent immune surveillance against Epstein-Barr virus [J].
Howie, D ;
Sayos, J ;
Terhorst, C ;
Morra, M .
CURRENT OPINION IN IMMUNOLOGY, 2000, 12 (04) :474-478